Press release
Biosimilars Market: Accelerating Growth Pushed by Increased Cancer Prevalence and R&D Expenditure; Projected CAGR of 17.7% by 2029
Biosimilars Market Size
What Is The Projected Market Size Of The Global Biosimilars Market And Its Growth Rate?
• Historic period growth (2024-2025): From $18.65 billion to $21.95 billion; attributed to increased cancer prevalence, strong economic development in emerging markets, heightened pharmaceutical R&D expenditure, and government initiatives among other factors.
• Forecast period growth (2025-2029): Expected to reach $42.16 billion driven by increasing demand for prophylaxis with granulocyte colony-stimulating factor (G-CSF), advances in technology, and high penetration of biological drugs, among other reasons.
What Is Driving The Growth In The Biosimilars Market?
The escalating prevalence of chronic diseases, such as arthritis and cancer, is a significant driving force for the biosimilars market. Factors such as long working hours, limited physical activity, and unhealthy dietary habits contribute to the rise in these diseases, thereby increasing the demand for biosimilars that help treat these conditions. According to a United Nations article, by 2030, chronic diseases are expected to account for 70% of all global deaths. Hence, the increasing burden of chronic diseases is projected to accelerate the demand for biosimilars.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2807&type=smp
Who Are the Key Players Driving Biosimilars Market Growth?
Major companies involved in the biosimilars market include:
• Amgen
• Novartis AG
• Samsung Bioepis Co., Ltd.
• Viatris
• Celltrion, Inc.
• Coherus Biosciences
• Eli Lilly and Company
• Dr. Reddy's Laboratories
• Roche India Pvt Ltd
• Abbott India Limited
• bioMérieux India
• Becton Dickinson Private Limited
and others.
What Are The Key Trends In The Biosimilars Market?
Major trends in the biosimilars market include:
• Robust R&D activities for the development of effective drugs
• Emphasis on M&A growth strategies
• Establishment of strategic partnerships
• Increased investments
• Application of artificial intelligence in drug development
What Are The Segments Of The Global Biosimilars Market?
The global biosimilars market is segmented based on:
• Type: Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones, Others
• Product: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins
• Application: Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications
Which Region Leads The Biosimilars Market?
North America dominated the global biosimilars market in 2024. However, the Middle East is expected to witness the fastest growth during the forecast period. The report covers various regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report
What Is Covered In The Biosimilars Market Global Market Report?
- Market Size Analysis: Analyze the Biosimilars Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Biosimilars Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Biosimilars Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Biosimilars Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request customization for this report:
https://www.thebusinessresearchcompany.com/customise?id=2807&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market: Accelerating Growth Pushed by Increased Cancer Prevalence and R&D Expenditure; Projected CAGR of 17.7% by 2029 here
News-ID: 3835617 • Views: …
More Releases from The Business Research Company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
